JOSE ISRAEL MARTINEZ-SALAS NPI 1396714838

NPI Details

Jose Israel Martinez-salas is a pulmonary disease internal medicine in Winter Haven, FL with 36 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. Jose Israel Martinez-salas NPI is 1396714838. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE
Graduation Year:1989

The provider's business location address is:

635 1ST ST N
WINTER HAVEN, FL
ZIP 33881-129
Phone: (863) 294-0670
Fax: (863) 298-3200

The NPI 1396714838 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• X-ray of chest, 2 views (HCPCS:71046)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroid hormone, t3 measurement, total (HCPCS:84480)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Blood test, clotting time (HCPCS:85610)
• Extended patient service without direct patient contact, first hour (HCPCS:99358)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Follow-up nursing facility visit per day, typically 35 minutes (HCPCS:99310)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Coronavirus vaccine 14 (HCPCS:91313)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Sarscov2 vac 50mcg/0.25ml im (HCPCS:91306)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Initial hospital observation care per day, typically 70 minutes (HCPCS:99220)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Ct scan of chest without contrast (HCPCS:71250)
• Bacterial colony count, urine (HCPCS:87086)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Hemoglobin a1c level (HCPCS:83036)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Ldl cholesterol level (HCPCS:83721)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Follow-up observation care per day, typically 35 minutes (HCPCS:99226)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Test for exercise-induced lung stress (HCPCS:94618)
• Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation (HCPCS:G0399)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Vitamin d-3 level (HCPCS:82306)
• X-ray of abdomen, 2 views (HCPCS:74019)
• X-ray of paranasal sinus, minimum of 3 views (HCPCS:70220)
• Electrocardiogram (ecg) 2-day continuous (HCPCS:93225)
• Electrocardiogram (ecg) 2-day continuous with report (HCPCS:93226)
• Electrocardiogram (ecg) 2-day continuous with review by health care professional (HCPCS:93227)
• X-ray of chest, 1 view (HCPCS:71045)
• Screening 3d breast mammography (HCPCS:77063)
• Screening mammography (HCPCS:77067)
• Low dose ct scan of chest for lung cancer screening (HCPCS:71271)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use (HCPCS:91301)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)

The enumeration date for this NPI number is 3/16/2006 and was last updated on 6/12/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.